Archive for the 'NIH' category

Salary Cap and the BRDPI Inflation Estimate

Jul 16 2015 Published by under Fixing the NIH, NIH Budgets and Economics

Wow. I last used the BRDPI estimate of inflation in the cost of biomedical research to illustrate how the full modular grant ($250K direct) had not changed and therefore purchasing power had eroded.

Jeff Mervis at Science has a blockbuster observation.

To remind you, the BRDPI is this:

The annual change in the Biomedical Research and Development Price Index (BRDPI) indicates how much the NIH budget must change to maintain purchasing power. The BRDPI was developed and is updated annually by the Bureau of Economic Analysis (BEA), Department of Commerce under an interagency agreement with the NIH.

That link also leads you to the data tables where you find the annual rates stretching back to the 50s.

The Mervis article highlights the historical low for FY2012 and reminds us of the cut in the salary cap (maximum amount of an Investigator's salary that can be charged to NIH grants)

Congress passed a spending bill in December 2011 that lowered the salary ceiling for investigators on a standard NIH grant from $199,700 to $179,700.

and concludes with a caution:

NIH enjoys strong support in Congress, and the realization that biomedical inflation largely tracks salary trends, not the sticker price of essential lab equipment and supplies, is unlikely to have a major impact on policy debates. Still, it may behoove biomedical lobbyists to think twice before citing the cost of high-tech science as a rationale for pumping up NIH's budget.

Yeah, I hear that. Let's peer a little closer though.

The NIH Office of the Budget January 2015 overview [PDF] futher anticipates that salary cap is a major driver of the inflation index.

The modest BRDPI growth rate of 2.0 percent for FY 2014 reflects the effect of the NIH extramural investigator salary limitation (“cap”) of $181,500 and an increase on salaries of Federal civilian employees of 0.75 percent for that fiscal year.
The projected 2.2 percent growth for FY 2015 assumes a one percent increase for Federal salaries starting in January 2015, as well as an increase on the extramural investigator salary cap to $183,300.

OK, let's route ourselves back to the NIH Office of the Budget report from January 2013 [PDF] which indeed draws an explicit link.

The modest BRDPI growth rate of 1.4 percent for FY 2012 reflects the effect of the reduction of the NIH extramural investigator salary limitation (“cap”) from $199,700 to $179,700 for that year and the continued freeze on salaries of Federal civilian employees.

However, it also goes on to note other contributions:

The BRDPI growth rate was also adjusted for the growth of stipends and related expenses on fellowships and training awards. In addition, the FY 2012 BRDPI growth is lower than the growth for FY 2011 because the rate of growth of prices for several input categories slowed down in FY 2012 compared with the growth during FY 2011. For inside NIH activities, the categories with slower growth in prices include travel, transportation, printing and reproduction, ADP and other IT services, instruments and apparatus, laboratory supplies, office supplies, utilities, repairs and alterations of facilities, compensation rates for consultants and support contracts. For extramural activities, fringe benefits, travel, equipment, supplies, patient care alterations and indirect costs each showed slower price growth during FY 2012 compared with FY 2011.

Wait. Sooooo, everything contributes a little bit? This seems out of step with Mervis' column. Wait, wait....the 2013 overview continues....

Primarily because of the freeze on Federal civilian employee salaries and the cap on compensation of extramural investigators, the rate of growth of the BRDPI during the years FY 2011 through FY 2013 has been relatively low compared with its historical relationship with general inflation as represented by the growth of the GDP Price Index.

Primarily. So that circles us right back to the reduction in the extramural cap and elimination of Federal civilian salary raises. [You might ask why the Federal civilians did not also suffer salary reductions, merely freezes, eh?] But if we take this as a valid and intended connotation then it would seem Mervis has it right. The salary issues are huge.

I wonder why they didn't just find the dollar figure. How many Investigators funded by the NIH in a given year are paying up to the cap? Multiply that by you favored reduction or increase and boom, you can translate that into new R01s.

The annual Salary Cap numbers can be found here. It seemed to steadily increase from 2005-2010, including that 2008-2009 interval that produced the most immediately prior reduction in the BRDPI. So why didn't salary cap drive the BRDPI that year?

30 responses so far


Jul 10 2015 Published by under Careerism, Fixing the NIH, Postdoctoral Training


Lastly, there IS one way to experimentally test how much a PD is worth, at least to PIs, and you are promoting that test, whether you know it or not. And that is a PD strike. I would love to see you discussing how spoiled PDs are in between gel runs because your PD is really not there. I think 50K/yr wouldn't sound that much then.

Go ahead dudes, you have nothing to lose but your chains.

22 responses so far

Will Obama's revamp of the overtime rules mean postdocs are paid more?

Jul 06 2015 Published by under Careerism, NIH Careerism, Postdoctoral Training

Justin Kiggins has launched the discussion at The Spectroscope.

Those postdocs who are salaried employees, however, are currently "exempt" from overtime pay if they make more than $23,660. The new rules mean that they will need a salary of at least $50,400. So if their institution is following the NIH standard, which sets a minimim of $42,840, it looks like they'll either need to get paid overtime for any work done over 40 hours or get a raise to meet the exemption requirements

Go on over and read, especially for the links to places you can comment on this rule prior to implementation.

184 responses so far

Grumble of the Day

Jul 06 2015 Published by under NIH, NIH Careerism, NIH funding

I still get irritated every time a PO gives me some grant advice or guidance that is discordant with my best understanding of the process. It's not so much that I take it seriously for my own strategy...I've been around this block once or twice. 

What kills me is thinking that there are poor newcomer applicants who get this advice and may think it is Gospel. This would then lead them into making suboptimal strategic or tactical decisions.

Related Reading:
POs do not understand...

28 responses so far

On recruiting peers to review NIH grants

Jun 30 2015 Published by under NIH, NIH Careerism

May 2015 Advisory Council round for the CSR of NIH.

I'll be making observations on the Luci Roberts presentation in a little while. For now, enjoy.


Okay, down to business. The part I wanted to highlight starts at 1:35 of the videocast. Dr. Nakamura introduces Luci Roberts, Director of Planning and Evaluation in the OER.

A comment from baltogirl

It is a little known fact that SROs have trouble recruiting for study section (I was told that two-thirds of people asked decline to serve). It's likely that most people are so busy writing their own grants they can't take a full month off to devote to reading the work of others.

reminded me I forgot to discuss these data.

The Division of Planning and Evaluation conducted a survey** some time ago, trying to determine the attitudes of extramural PIs that would affect their willingness to serve on study sections. I thought it applied to the above comment.
They surveyed 4,000 individuals who had submitted at least one grant as PI in the past five years and who had obtained active funding (any variety) from the NIH in the past five years. 1830 or 46% responded. Not too shabby. (They also surveyed 423 SROs of which 271/64% responded, more on that later.) Of the PIs 1,616 had served as PIs or PDs, the balance were TG directors or subproject/consortium PIs.

First up. 964 (53%) had never been asked to serve on study section in the 12 months prior to the survey. Hmm. I can almost stop right here. But no....there's much more. Still, if there is a reviewer crunch, the first order of business is to determine why over half the potential pool is not even being asked.

Ok, of the remaining 866 individuals who were asked to serve on study section, 762 agreed to do so. That's 88% saying yes. So the rumor that "two-thirds of people asked decline to serve" is falsified by this survey. Clearly, the vast majority of people who are asked step up and do their community duty.

I really, really like this. It is heartening.

The next most-interesting thing was the 10th slide which shows the ranks of PIs who are asked/not asked to review. As you would expect, the Full/Associate/Assistant Professor ranks for those asked ran 54%/32%/11% (that high for Assistants?) and 22%/23%/37% for those not asked to serve.

Again, this outcome makes it really clear what needs to be done if getting reviewers is a problem. Ask more Assistant Professors to serve***. Right? Done.

Then we get into a couple of slides on why people might say "no" when asked to review. Slide 11 present the top reasons (out of an open text box response, per Roberts' presentation) for the process being "more burdensome than it could be". The numbers are confused here because the denominator appears to be 861 when it should be 762. But in any case, 630 of the respondents who reviewed said the process was not more burdensome than necessary (huh? surprised on this one). Of the 158 who said it was too burdensome, 45% complained about the number of assigned applications. The next most common (16%) complaint was "too much time devoted to applications that will never fund". So pretty much, the most burdensome thing was review load.

This brings us to Slide 13 which pits SRO opinion versus how reviewers think. One of the biggest disconnects was in the number of in-person meetings per year that is "reasonable" since reviewers lean 1-2 and SROs were about evenly split between 1-2 and 3-4 as okay. A similar disconnect was found on application load. Half of the reviewers felt 4-6 apps was a reasonable load and only 25% felt 7-9 was reasonable. SROs leaned 7-9 (~60% of SROs) with less than 40% finding a 4-6 grant load reasonable.


I'm skipping Slide 12 on reviewer and SRO thoughts on reason to accept and decline invitations to review since 88% of those asked say yes anyway. Who cares what they say if most of them will do it just for the asking?

Okay, those were the things that jumped out at me.

*As a disclosure, Dr. Roberts was once a SRO who played a highly formative role in the early-career understanding of the NIH grant business for YHN. She was kind enough to send me the slide deck that was used in her presentation.

**I was a respondent, fwiw.

***In case of any newcomers, both YHN and CPP have advocated for this on this blog since forever.

16 responses so far

Question of the day

Jun 29 2015 Published by under Fixing the NIH, NIH, NIH Careerism

What percentage of K99 should fail to transition to the R00 phase in a healthy system?
What percentage of those that go to R00 should fail to ever gain major independent funding as a PI? 

38 responses so far

A Tweet which captures the problem with NIH's "pipeline" response to Ginther

Jun 29 2015 Published by under NIH, NIH Careerism

14 responses so far

PhysioProffe on the conduct of science

Jun 25 2015 Published by under Careerism, Conduct of Science, NIH

go read:

Self-interested nepotistic shittebagges constantly assert this parade of horribles that if we don’t fund the right subset of scientists in today’s tight scientific funding environment (coincidentally them, their friends, their trainees, and their family members), then we are going to destroy scientific progress. This is because they are delusional......

No responses yet

Peer review and the death sentence

Jun 25 2015 Published by under NIH, NIH Careerism

It is relatively easy to kill grant applications because the reviewer knows the applicant can always apply again.

Same thing for hiring decisions because surely some lesser University will hire the three other candidates on the short list.

In many tenure cases, the Department knows that this person will get a professorial rank job elsewhere*.

Germain's scheme is going to require peers in the field to pass a death sentence on the career. And to make the numbers add up, there will be a LOT of this.

Those peers know that they themselves will be up for chopping in the next 5-7 years.

I do not foresee much enthusiasm for scoring progress as deficient and this will only grow more intense with each successive 5 year review interval.

*and anyway these are so personal at this point that it is a different matter.

15 responses so far

Republicans of Science

Jun 25 2015 Published by under NIH, Tribe of Science

10 responses so far

Older posts »